Ditchcarbon
  • Contact
  1. Organizations
  2. CROMA-PHARMA GmbH
Public Profile
Pharmaceutical Preparation Manufacturing
AT
updated a month ago

CROMA-PHARMA GmbH

Company website

CROMA-PHARMA GmbH, a leading player in the pharmaceutical and medical device industry, is headquartered in Austria (AT) and operates extensively across Europe and beyond. Founded in 2003, the company has established itself as a pioneer in the development and distribution of innovative aesthetic and therapeutic solutions, particularly in the fields of dermal fillers and regenerative medicine. CROMA-PHARMA's core products, including the renowned Princess® line of dermal fillers, are distinguished by their high-quality formulations and commitment to safety. The company’s focus on research and development has led to significant advancements in minimally invasive treatments, positioning it as a trusted name among healthcare professionals. With a strong market presence and a dedication to excellence, CROMA-PHARMA continues to achieve notable milestones in enhancing patient care and aesthetic outcomes.

DitchCarbon Score

How does CROMA-PHARMA GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

34

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

CROMA-PHARMA GmbH's score of 34 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

56%

Let us know if this data was useful to you

CROMA-PHARMA GmbH's reported carbon emissions

In 2024, CROMA-PHARMA GmbH reported carbon emissions of approximately 768,000 kg CO2e, a decrease from about 804,000 kg CO2e in 2023. The company has disclosed emissions data for Scope 2 only, with no data available for Scope 1 or Scope 3 emissions. In 2022, the total emissions were about 7,538 kg CO2e, which included 1,081 kg CO2e from Scope 1, 4,516 kg CO2e from Scope 2, and 6,452 kg CO2e from Scope 3. CROMA-PHARMA has set ambitious climate commitments, aiming for net-zero emissions for both Scope 1 and Scope 2 by 2035, with a baseline year of 2023. This target reflects a commitment to reduce emissions by 100% in these scopes. The company's climate initiatives are part of a long-term strategy to enhance sustainability and reduce its carbon footprint. The emissions data is cascaded from CROMA-PHARMA GmbH as a current subsidiary, with no additional data sourced from parent or related organizations. The company is actively working towards its climate goals, demonstrating a proactive approach to environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
1,081
-
-
Scope 2
4,516
000,000
000,000
Scope 3
6,452
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CROMA-PHARMA GmbH's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CROMA-PHARMA GmbH is in AT, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CROMA-PHARMA GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ipsen

FR
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Galderma Group AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Hugel, Inc.

KR
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Revance Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 11 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy